| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |